Salix Pharmaceuticals, Ltd. Says Watson Pharmaceuticals, Inc. to Sell Generic Anti-Inflammatory Drug; Salix Shares Sink

December 31, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Dec 28 (Reuters) - Salix Pharmaceuticals Ltd (SLXP.O: Quote, Profile, Research) said Watson Pharmaceuticals Inc (WPI.N: Quote, Profile, Research) will market an authorized generic of its anti-inflammatory drug, Colazal.

Twitter
LinkedIn
Facebook
Email
Print